Tag: stage

LUXEMBOURG, Aug. 10, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a decentralized financial operating system integrating programmable PoY (Proof of Yield) rewards, AI-powered smart contracts, decentralized identity, and a hybrid PoW plus PoS consensus, has announced the latest developments in its Stage 4 presale. The presale is currently priced at $4, with a planned launch price of $15, offering Stage 4 participants an APY of 106%.

ROAD TOWN, British Virgin Islands, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Ozak AI’s growth is showing no signs of slowing down, with the project now surpassing $1.6 million in total funds raised. Over 90 million $OZ tokens have already been sold out, demonstrating the surging demand from crypto investors keen to gain exposure to one of the most talked-about AI-driven crypto initiatives this year.

GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support solutions.

LUXEMBOURG, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a next-generation financial protocol combining AI-powered smart contracts with decentralized identity governance, has officially entered Stage 4 of its presale. The project reports over $580,000 in total contributions, 2,100+ buyers, and an APY of 106% for participants who join before the stage concludes.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES
OR FOR DISSEMINATION IN THE UNITED STATES

MIAMI, FL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MIAMI, FL – August 8, 2025 – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the first fiscal quarter ended June 30, 2025.

Photo Courtesy of Lithios Beverages

Prize AI Technologies launched a $PRIZE token presale, raising $100K+ in the first week and targeting the $400B arcade/casino market. The platform integrates AI analytics with blockchain rewards through a consumer app and an operator dashboard. Stage 1 tokens are priced at $0.01 and have 33% APR staking yields.

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.

CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.^® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).